1. Adding Nasal Decolonization to Infection Prevention Bundles

    May 30, 2017

    Infection Prevention Bundles with Nasal DecolonizationA bundle approach has been used to support prevention of many types of healthcare associated infections including CLABSI, CAUTI, VAP, and SSI.  Over the past few years, nasal decolonization has been added as a bundle element with increasing frequency, to reduce the risk of all of these types of infections.  […]

  2. Update from Marshall Medical Center – Eliminating MRSA Contact Precautions

    February 3, 2017

    Marshall Medical Center, which includes Marshall Hospital, a fully accredited acute care facility with 113 beds located in Placerville and several outpatient facilities, adopted Nozin® Nasal Sanitizer® as part of their screen and treat protocol in 2015.At the APIC 2016 conference, Nina Deatherage, BSN, RN, PHN, CIC, presented results of eliminating MRSA contact precautions at […]

  3. Nozin® Pre-Op Pack – Nasal Decolonization without Antibiotics or Iodine

    August 30, 2016

    Reduce S. aureus nasal carriage 99%* day of surgery with the new Nozin® Pre-Op Pack.  Nozin® Nasal Sanitizer® Antiseptic Preoperative Pack provides fast, effective reduction of nasal pathogens without antibiotics or iodine, resulting in better care for patients and lower costs for facilities.Research shows nasal decolonization is critical to reduce HAI.  Nasal Sanitizer® Nozaseptin® patented formulation […]

  4. Staph Aureus in the Nose: Facts to Share with Patients

    February 2, 2016

    Staphylococcus is a group of bacteria some of which can cause a number of diseases as a result of infection of various tissues of the body. Infections can be caused by a particular type of Staphylococci called Staphylococcus aureus. Illnesses and infections that are Staph-related illness can fall into a spectrum of mild to severe and possibly […]

  5. What Healthcare Workers Need to Know about Staph aureus & Hospital Acquired Infections

    March 22, 2015

    Approximately 30% of the population carry the bacteria Staphylococcus aureus in their noses.  The Staph aureus residing in these nasal reservoirs can be a source for hospital acquired infections (HAIs). While Staph is not normally a problem in healthy individuals, those who are in hospitals are at a higher risk of acquiring a serious or even fatal Staph aureus infection.  Patients with open […]

  6. What Your Healthcare Facility Needs to Know about Nozin Nasal Sanitizer

    Nozin® Nasal Sanitizer® antiseptic is clinically proven to provide reduction of Staph aureus nasal carriage. Nozin® Nasal Sanitizer® is an advanced antiseptic and a new approach for hospitals that are taking steps to help reduce the risk of the transmission of pathogens, such as Staph aureus.  Helath professionals regard Nozin® Nasal Sanitizer® as an innovation in infection control […]

  7. Review Why Health Professionals Recommend Nozin

    August 26, 2014

    Health Professionals recommend Nozin Nasal Sanitizer because they know the benefits of nasal hygiene and the clinical effectiveness of the product. They know that Nozin Nasal Sanitizer has been shown to decrease nasal bacteria carriage without antibiotics and can help reduce the risk of infection. They also know the product is safe, well tolerated and […]

  8. What is the Chain of Infection?

    January 14, 2014

    Infection transmission occurs when the agent leaves its reservoir or host through a portal of exit, is conveyed by some mode of transmission, and enters through an appropriate portal of entry to infect a susceptible host.  The six links that must all be present (and in sequential order) for an infection to develop are:  infectious agent, reservoir, portal of exit from the reservoir, mode of […]

Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2023 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.